Duff & Phelps Investment Management Co. Sells 94,730 Shares of Danaher Co. (NYSE:DHR)

Duff & Phelps Investment Management Co. decreased its stake in shares of Danaher Co. (NYSE:DHR) by 52.3% during the fourth quarter, Holdings Channel reports. The firm owned 86,234 shares of the conglomerate’s stock after selling 94,730 shares during the quarter. Duff & Phelps Investment Management Co.’s holdings in Danaher were worth $19,949,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. Banco Santander S.A. purchased a new position in shares of Danaher in the 3rd quarter worth $683,000. First Citizens Bank & Trust Co. grew its stake in shares of Danaher by 0.6% during the 4th quarter. First Citizens Bank & Trust Co. now owns 26,611 shares of the conglomerate’s stock valued at $6,156,000 after purchasing an additional 149 shares during the period. Cercano Management LLC increased its position in shares of Danaher by 11.4% during the 4th quarter. Cercano Management LLC now owns 202,569 shares of the conglomerate’s stock valued at $46,862,000 after purchasing an additional 20,715 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Danaher by 48.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 296,996 shares of the conglomerate’s stock worth $68,707,000 after purchasing an additional 96,395 shares during the period. Finally, Parkside Financial Bank & Trust boosted its holdings in shares of Danaher by 4.8% in the third quarter. Parkside Financial Bank & Trust now owns 3,080 shares of the conglomerate’s stock worth $764,000 after buying an additional 142 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.6 %

NYSE DHR traded down $1.38 during trading hours on Tuesday, hitting $245.44. 1,016,627 shares of the company were exchanged, compared to its average volume of 2,749,436. Danaher Co. has a 52 week low of $182.09 and a 52 week high of $259.00. The company has a quick ratio of 1.51, a current ratio of 1.85 and a debt-to-equity ratio of 0.31. The stock has a 50-day moving average price of $248.80 and a 200 day moving average price of $231.53. The stock has a market cap of $181.79 billion, a PE ratio of 41.83, a price-to-earnings-growth ratio of 3.80 and a beta of 0.83.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.20. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.36 EPS. Analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Thursday, March 28th were paid a dividend of $0.27 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date of this dividend was Wednesday, March 27th. Danaher’s payout ratio is currently 18.31%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on DHR shares. KeyCorp upped their target price on shares of Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a report on Thursday, February 1st. Bank of America upped their price target on Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 24th. Robert W. Baird boosted their price objective on Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a research note on Wednesday, April 24th. TD Cowen upped their target price on shares of Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Finally, Raymond James boosted their price target on Danaher from $240.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Six analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $269.64.

Insider Transactions at Danaher

In other news, EVP Joakim Weidemanis sold 22,433 shares of the firm’s stock in a transaction that occurred on Thursday, April 25th. The shares were sold at an average price of $250.46, for a total transaction of $5,618,569.18. Following the transaction, the executive vice president now directly owns 90,412 shares of the company’s stock, valued at $22,644,589.52. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Danaher news, CEO Rainer Blair sold 47,175 shares of the stock in a transaction dated Wednesday, April 24th. The shares were sold at an average price of $249.22, for a total transaction of $11,756,953.50. Following the transaction, the chief executive officer now directly owns 115,995 shares in the company, valued at approximately $28,908,273.90. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Joakim Weidemanis sold 22,433 shares of the business’s stock in a transaction dated Thursday, April 25th. The shares were sold at an average price of $250.46, for a total transaction of $5,618,569.18. Following the completion of the sale, the executive vice president now owns 90,412 shares of the company’s stock, valued at approximately $22,644,589.52. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 106,565 shares of company stock worth $26,641,364. Insiders own 10.90% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.